Tumour necrosis as assessed with <sup>18</sup>F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements.

Kahle, Xaver U; Hovingh, Menno; Noordzij, Walter; Seitz, Annika; Diepstra, Arjan; Visser, Lydia; van den Berg, Anke; van Meerten, Tom; Huls, Gerwin; Boellaard, Ronald; Kwee, Thomas C; Nijland, Marcel

Tumour necrosis as assessed with ¹⁸F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements.

Kahle, Xaver U; Hovingh, Menno; Noordzij, Walter; Seitz, Annika; Diepstra, Arjan; Visser, Lydia; van den Berg, Anke; van Meerten, Tom; Huls, Gerwin; Boellaard, Ronald; Kwee, Thomas C; Nijland, Marcel.

Afiliação

Kahle XU; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. x.kahle@umcg.nl.
Hovingh M; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Noordzij W; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Seitz A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Visser L; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van den Berg A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van Meerten T; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Huls G; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Boellaard R; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Kwee TC; Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Nijland M; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Eur Radiol ; 29(11): 6018-6028, 2019 Nov.

Article em En | MEDLINE | ID: mdl-31028445

Assuntos

Fluordesoxiglucose F18; Linfoma Difuso de Grandes Células B/diagnóstico por imagem; Tomografia por Emissão de Pósitrons/métodos; Compostos Radiofarmacêuticos; Adulto; Idoso; Feminino; Rearranjo Gênico do Linfócito B/genética; Genes myc/genética; Glicólise/fisiologia; Humanos; Linfoma Difuso de Grandes Células B/genética; Masculino; Pessoa de Meia-Idade; Análise Multivariada; Prognóstico; Estudos Retrospectivos; Análise de Sobrevida; Carga Tumoral

Palavras-chave

Diffuse, large B cell, lymphoma; Fluorodeoxyglucose F18; MYC oncogene; Necrosis; Positron emission tomography

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google